{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:02:09Z","timestamp":1790607729230,"version":"4.1.0"},"reference-count":36,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR AI"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Antiseizure medications (ASMs) are the mainstay of epilepsy treatment; however, there is currently no reliable way to predict which medication will be most effective for an individual patient. Machine learning (ML) approaches are increasingly being explored to support personalized ASM selection, but successful implementation will depend on acceptance by both people with epilepsy and treating neurologists. Understanding factors influencing acceptability of ML in clinical decision-making is therefore critical to support engagement, trust, and adherence. The extended unified theory of acceptance and use of technology (UTAUT2) framework has previously been applied to evaluate acceptance of health care technologies, but its suitability for ML-supported ASM selection has not been established.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The objective of this study was to co-design a UTAUT2-based questionnaire to measure ML technology acceptability that is suitable for use in a clinical trial.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Adults living with epilepsy and prescribing neurologists were recruited using purposive sampling to participate in a co-design process evaluating the relevance, comprehensiveness, and clarity of the UTAUT2 framework in this clinical context. Participants completed an online survey that collected structured feedback on existing UTAUT2 constructs and identified additional factors influencing ML acceptance. Quantitative responses were analyzed descriptively, and qualitative responses were analyzed thematically to inform adaptation of the framework and development of a context-specific ML acceptability questionnaire.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 32 participants completed the survey, including 22 (68.8%) adults living with epilepsy and 10 (31.2%) neurologists. While participants considered core UTAUT2 constructs relevant, qualitative feedback identified additional domains influencing ML acceptance, including emotional attitudes, perceived risks, knowledge enhancement, conflicts in shared decision-making, and contextual factors such as workplace policy and regulation. On the basis of this feedback, the ML acceptability questionnaire for ASM selection retained relevant UTAUT2 domains and incorporated additional constructs addressing trust and perceived risk. Other themes provided contextual insights for interpretation of ML acceptability and future implementation.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study highlights the importance of co-design when adapting existing frameworks to the specific clinical context. The co-designed ML acceptance questionnaire for ASM selection developed in this study can be used to evaluate the acceptability of ML technology in the field of epilepsy, strengthening future trials and supporting ongoing technology development.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/85047","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:53:34Z","timestamp":1790607214000},"page":"e85047-e85047","source":"Crossref","is-referenced-by-count":0,"title":["Acceptance of Machine Learning for Medication Selection in Epilepsy to Inform Clinical Trial Design: Co-Design Survey Study"],"prefix":"10.2196","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-9484","authenticated-orcid":false,"given":"Madeleine J","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-0179","authenticated-orcid":false,"given":"Sandra","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0786-6113","authenticated-orcid":false,"given":"Fiona","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9579","authenticated-orcid":false,"given":"Shobi","family":"Sivathamboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8958-3844","authenticated-orcid":false,"given":"Emma C","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8939-2885","authenticated-orcid":false,"given":"Daniel","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-6917","authenticated-orcid":false,"given":"Zhibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-276X","authenticated-orcid":false,"given":"Patrick","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-8345","authenticated-orcid":false,"given":"Natasha A","family":"Lannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","journal-title":"Neurology"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","journal-title":"Epilepsia"},{"issue":"3","key":"R3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","journal-title":"JAMA Neurol"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g254","article-title":"Drug treatment of epilepsy in adults","volume":"348","author":"Schmidt","journal-title":"BMJ"},{"issue":"2","key":"R5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1017\/s1092852900008464","article-title":"The consequences of uncontrolled epilepsy","volume":"9","author":"Sperling","journal-title":"CNS Spectr"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2023.107096","article-title":"Experience of waiting for seizure freedom and perception of machine learning technologies to support treatment decision: a qualitative study in adults with recent onset epilepsy","volume":"190","author":"Reeder","journal-title":"Epilepsy Res"},{"issue":"13","key":"R7","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","article-title":"Big data and machine learning in health care","volume":"319","author":"Beam","journal-title":"JAMA"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04698-z","article-title":"Revolutionizing healthcare: the role of artificial intelligence in clinical practice","volume":"23","author":"Alowais","journal-title":"BMC Med Educ"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108273","article-title":"Machine learning models for decision support in epilepsy management: a critical review","volume":"123","author":"Smolyansky","journal-title":"Epilepsy Behav"},{"issue":"10","key":"R10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamaneurol.2022.2514","article-title":"Development and validation of a deep learning model for predicting treatment response in patients with newly diagnosed epilepsy","volume":"79","author":"Hakeem","journal-title":"JAMA Neurol"},{"issue":"4","key":"R11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-086607","article-title":"Personalised selection of medication for newly diagnosed adult epilepsy: study protocol of a first-in-class, double-blind, randomised controlled trial","volume":"15","author":"Thom","journal-title":"BMJ Open"},{"issue":"12","key":"R12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11910-023-01318-7","article-title":"Machine learning and artificial intelligence applications to epilepsy: a review for the practicing epileptologist","volume":"23","author":"Kerr","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"R13","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/S2589-7500(24)00047-5","article-title":"Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review","volume":"6","author":"Han","journal-title":"Lancet Digit Health"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.2196\/72184","article-title":"Acceptability of health information technology by health care professionals: where we are now and how we can fill the gap","volume":"27","author":"Isnard-Bagnis","journal-title":"J Med Internet Res"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/00187208211064707","article-title":"Review of the factors affecting acceptance of AI-infused systems","volume":"66","author":"Ismatullaev","journal-title":"Hum Factors"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2307\/41410412","article-title":"Consumer acceptance and use of information technology: extending the unified theory of acceptance and use of technology","volume":"36","author":"Venkatesh","journal-title":"MIS Q"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2022-100640","article-title":"Extension of the unified theory of acceptance and use of technology 2 model for predicting mHealth acceptance using diabetes as an example: a cross-sectional validation study","volume":"29","author":"Schretzlmaier","journal-title":"BMJ Health Care Inform"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","DOI":"10.2196\/27095","article-title":"Applying an extended UTAUT2 model to explain user acceptance of lifestyle and therapy mobile health apps: survey study","volume":"10","author":"Schomakers","journal-title":"JMIR Mhealth Uhealth"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.2196\/42087","article-title":"Predicting habitual use of wearable health devices among middle-aged individuals with metabolic syndrome risk factors in South Korea: cross-sectional study","volume":"7","author":"Ha","journal-title":"JMIR Form Res"},{"issue":"4","key":"R20","doi-asserted-by":"publisher","DOI":"10.1177\/21582440221142209","article-title":"Developing an extended theory of UTAUT 2 model to explore factors influencing Taiwanese consumer adoption of intelligent elevators","volume":"12","author":"Chu","journal-title":"Sage Open"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-026-03357-9","article-title":"Intention to use smartphone medical applications among patients with chronic disease in southwest Ethiopia: an extended UTAUT2 model approach","volume":"26","author":"Butta","journal-title":"BMC Med Inform Decis Mak"},{"key":"R22","unstructured":"CodesignKit. URL: http:\/\/codesignkit.org.au\/ [Accessed 17-09-2026]"},{"issue":"3","key":"R23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1503\/cmaj.080372","article-title":"A guide for the design and conduct of self-administered surveys of clinicians","volume":"179","author":"Burns","journal-title":"CMAJ"},{"issue":"9","key":"R24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","journal-title":"Qual Health Res"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijinfomgt.2020.102269","article-title":"The extended unified theory of acceptance and use of technology (UTAUT2): a systematic literature review and theory evaluation","volume":"57","author":"Tamilmani","journal-title":"Int J Inf Manag"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1177\/1847979019889484","article-title":"Customer acceptance of mobile marketing in Jordan: an extended UTAUT2 model with trust and risk factors","volume":"11","author":"Eneizan","journal-title":"Int J Eng Bus Manag"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.2196\/46548","article-title":"Factors influencing the acceptability, acceptance, and adoption of conversational agents in health care: integrative review","volume":"25","author":"Wutz","journal-title":"J Med Internet Res"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043139","article-title":"Understanding use intention of mHealth applications based on the unified theory of acceptance and use of technology 2 (UTAUT-2) model in China","volume":"20","author":"Zhu","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"R29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19095643","article-title":"Factors influencing the perceived effectiveness of COVID-19 risk assessment mobile application \u201cMorChana\u201d in Thailand: UTAUT2 approach","volume":"19","author":"Yuduang","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07339-7","article-title":"Factors affecting physicians using mobile health applications: an empirical study","volume":"22","author":"Wu","journal-title":"BMC Health Serv Res"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI230007","article-title":"Predicting mHealth acceptance using the UTAUT2 technology acceptance model: a mixed-methods approach","volume":"301","author":"Schretzlmaier","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"R32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1518\/hfes.46.1.50_30392","article-title":"Trust in automation: designing for appropriate reliance","volume":"46","author":"Lee","journal-title":"Hum Factors"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116357","article-title":"Multi-stakeholder preferences for the use of artificial intelligence in healthcare: a systematic review and thematic analysis","volume":"338","author":"Vo","journal-title":"Soc Sci Med"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.2196\/74010","article-title":"Patient attitudes toward artificial intelligence in cancer care: scoping review","volume":"11","author":"Hilbers","journal-title":"JMIR Cancer"},{"issue":"7","key":"R35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/tbm\/ibab048","article-title":"Acceptability of digital health interventions: embracing the complexity","volume":"11","author":"Perski","journal-title":"Transl Behav Med"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"K\u00f6rber M . Theoretical considerations and development of a questionnaire to measure trust in automation. In: Proceedings of the 20th Congress of the International Ergonomics Association (IEA 2018). Springer International Publishing; 2019.","DOI":"10.1007\/978-3-319-96074-6_2"}],"container-title":["JMIR AI"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:53:35Z","timestamp":1790607215000},"score":1,"resource":{"primary":{"URL":"https:\/\/ai.jmir.org\/2026\/1\/e85047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":36,"URL":"https:\/\/doi.org\/10.2196\/85047","relation":{},"ISSN":["2817-1705"],"issn-type":[{"value":"2817-1705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"v5i3e85047"}}